Geode Capital Management’s Hoth Therapeutics HOTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Buy |
122,575
+9,071
| +8% | +$10.6K | ﹤0.01% | 3970 |
|
|
2025
Q1 | $114K | Buy |
113,504
+17,558
| +18% | +$17.6K | ﹤0.01% | 4001 |
|
|
2024
Q4 | $71.8K | Buy |
95,946
+13,038
| +16% | +$9.75K | ﹤0.01% | 4176 |
|
|
2024
Q3 | $73K | Buy |
82,908
+47,244
| +132% | +$41.6K | ﹤0.01% | 4179 |
|
|
2024
Q2 | $33K | Buy |
35,664
+10,101
| +40% | +$9.35K | ﹤0.01% | 4369 |
|
|
2024
Q1 | $38.9K | Buy |
25,563
+2,062
| +9% | +$3.13K | ﹤0.01% | 4370 |
|
|
2023
Q4 | $33.8K | Hold |
23,501
| – | – | ﹤0.01% | 4435 |
|
|
2023
Q3 | $35.7K | Sell |
23,501
-839
| -3% | -$1.28K | ﹤0.01% | 4505 |
|
|
2023
Q2 | $73K | Buy |
+24,340
| New | +$73K | ﹤0.01% | 4428 |
|
|
2022
Q4 | – | Sell |
-137,102
| Closed | -$47K | – | 4911 |
|
|
2022
Q3 | $47K | Hold |
137,102
| – | – | ﹤0.01% | 4777 |
|
|
2022
Q2 | $57K | Buy |
137,102
+16,741
| +14% | +$6.96K | ﹤0.01% | 4747 |
|
|
2022
Q1 | $83K | Hold |
120,361
| – | – | ﹤0.01% | 4709 |
|
|
2021
Q4 | $79K | Hold |
120,361
| – | – | ﹤0.01% | 4782 |
|
|
2021
Q3 | $143K | Buy |
120,361
+40,790
| +51% | +$48.5K | ﹤0.01% | 4566 |
|
|
2021
Q2 | $127K | Buy |
79,571
+60,779
| +323% | +$97K | ﹤0.01% | 4493 |
|
|
2021
Q1 | $37K | Hold |
18,792
| – | – | ﹤0.01% | 4423 |
|
|
2020
Q4 | $44K | Hold |
18,792
| – | – | ﹤0.01% | 4190 |
|
|
2020
Q3 | $37K | Hold |
18,792
| – | – | ﹤0.01% | 4058 |
|
|
2020
Q2 | $48K | Buy |
+18,792
| New | +$48K | ﹤0.01% | 3980 |
|